
1. General Information
Hepcinat Plus Tablet is an antiviral medicine containing Daclatasvir 60 mg and Sofosbuvir 400 mg. It belongs to the class of direct-acting antiviral medicines and is used as part of treatment for chronic hepatitis C (HCV) infection. Hepatitis C is a viral infection that primarily affects the liver and, if untreated, can lead to serious liver complications.
Hepcinat Plus is an oral prescription medicine and should be used under the supervision of a qualified healthcare professional. The exact treatment duration and whether additional medicines are required depend on factors such as HCV genotype, liver condition, previous treatment history and other patient-specific factors.
2. Product Information
Product Name: Hepcinat Plus Tablet
Active Ingredients: Daclatasvir 60 mg + Sofosbuvir 400 mg
Dosage Form: Film-coated oral tablet
Therapeutic Class: Direct-acting antiviral (DAA)
Primary Indication: Chronic Hepatitis C virus (HCV) infection
Manufacturer/Marketer: Natco Pharma Ltd.
Country of Origin: India
Indian government records identify Hepcinat Plus as a film-coated tablet containing Daclatasvir equivalent to 60 mg and Sofosbuvir 400 mg.
3. Uses of Hepcinat Plus
Hepcinat Plus is primarily used for the treatment of chronic hepatitis C infection.
It may be prescribed to help:
- Treat chronic HCV infection.
- Reduce the amount of hepatitis C virus in the bloodstream.
- Prevent ongoing viral activity that can contribute to liver damage.
- Achieve sustained virologic response (SVR), meaning HCV RNA remains undetectable after treatment.
The appropriate regimen should be selected by a healthcare professional according to the patient's HCV characteristics and clinical condition.
4. Benefits of Hepcinat Plus
The principal benefit of Hepcinat Plus is its direct antiviral activity against hepatitis C.
Potential treatment benefits include:
- Helps suppress HCV replication.
- Combines two antiviral agents with different targets in the HCV replication cycle.
- Can help clear detectable HCV from the bloodstream when used in an appropriate treatment regimen.
- May reduce the risk of progressive liver disease associated with persistent HCV infection.
- Oral tablet formulation can make treatment convenient compared with injectable treatment approaches.
Treatment success depends on the patient's specific HCV infection and adherence to the prescribed regimen.
5. Side Effects of Hepcinat Plus
Like other prescription medicines, Hepcinat Plus can cause side effects. Not everyone experiences them, and their severity can vary.
Possible adverse effects may include:
- Headache
- Fatigue or tiredness
- Nausea
- Weakness
- Digestive discomfort
- Sleep-related changes
Some side effects can also be related to other medicines used alongside Hepcinat Plus. Patients should inform their doctor about persistent, severe or unusual symptoms.
6. Common Side Effects
Commonly reported effects associated with Hepcinat Plus or its components may include:
- Headache
- Fatigue
- Nausea
- Weakness
- Mild gastrointestinal discomfort
If symptoms become severe, persistent or concerning, medical advice should be obtained rather than stopping treatment independently.
7. How to Use Hepcinat Plus
Hepcinat Plus should be taken exactly as prescribed by a doctor.
General administration guidance includes:
- Take the tablet orally with water.
- It may generally be taken with or without food.
- Try to take it at the same time each day.
- Swallow the tablet whole unless your healthcare professional gives different instructions.
- Do not change the dose or treatment duration without medical advice.
- Complete the prescribed course even if you begin to feel well.
If a dose is missed, follow your healthcare professional's instructions or the product information supplied with the medicine. Avoid taking extra doses to compensate unless specifically instructed.
8. How Hepcinat Plus Works
Hepcinat Plus contains two direct-acting antiviral medicines that target different stages of hepatitis C virus replication.
Sofosbuvir inhibits the HCV NS5B RNA-dependent RNA polymerase, an enzyme required by the virus to reproduce its genetic material.
Daclatasvir targets the HCV NS5A protein, which plays an important role in viral replication and assembly.
By inhibiting different viral targets, the combination can strongly suppress HCV replication and help the body's immune system clear the virus.
9. Safety Advice
Hepcinat Plus is a prescription antiviral medicine and should be used under appropriate medical supervision.
Important precautions include:
- Inform your doctor about all medicines, supplements and herbal products you take.
- Tell your doctor if you have liver or kidney problems.
- Tell your healthcare professional about previous hepatitis C treatment.
- Do not stop treatment prematurely without medical advice.
- Check for possible drug interactions before starting treatment.
- Certain medicines can reduce the effectiveness of Daclatasvir or Sofosbuvir.
- If you are taking medicines for other conditions, your doctor should review them before treatment begins.
- Patients who are pregnant, planning pregnancy or breastfeeding should discuss treatment with their healthcare professional.
- Seek medical attention for serious or unusual symptoms.
Because hepatitis C treatment is individualized, the treatment regimen and duration should be determined by a qualified healthcare provider.
10. Frequently Asked Questions (FAQs)
Q1. What is Hepcinat Plus used for?
Hepcinat Plus is used for the treatment of chronic hepatitis C virus infection.
Q2. What are the ingredients in Hepcinat Plus?
Each tablet contains Daclatasvir 60 mg and Sofosbuvir 400 mg.
Q3. Is Hepcinat Plus an antibiotic?
No. It is an antiviral medicine specifically used against hepatitis C virus.
Q4. Can Hepcinat Plus be taken without a prescription?
It should be used under medical supervision because HCV treatment requires appropriate diagnosis, treatment selection and monitoring.
Q5. Can Hepcinat Plus cure hepatitis C?
Appropriately selected direct-acting antiviral treatment can achieve viral clearance in many patients. Whether this particular regimen is appropriate depends on individual clinical factors.
Q6. Can I stop taking Hepcinat Plus when I feel better?
No. Do not stop treatment without consulting your doctor. Completing the prescribed regimen is important.
Q7. Can Hepcinat Plus interact with other medicines?
Yes. Daclatasvir and Sofosbuvir can interact with certain medicines. Your healthcare provider should review your complete medication list before treatment.
Q8. Should Hepcinat Plus be taken with food?
It may generally be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional or product information.
Q9. Is Hepcinat Plus an injectable medicine?
No. Hepcinat Plus is an oral tablet.
Q10. Who should determine the treatment duration?
A qualified healthcare professional should determine the treatment duration based on the patient's HCV infection, liver status, previous treatment and other clinical factors.
11. Substitutes for Hepcinat Plus
Possible alternatives may contain the same active ingredients—Daclatasvir 60 mg + Sofosbuvir 400 mg—but brand availability varies by country and market.
Examples of products containing the same combination may include:
- Generic Daclatasvir 60 mg + Sofosbuvir 400 mg combinations
- Other locally approved Daclatasvir/Sofosbuvir brands
A substitute should not be selected solely on the basis of brand name or price. A healthcare professional or pharmacist should confirm that the alternative has the same active ingredients, strength, quality and regulatory status.
12. SEO Keywords
- Hepcinat Plus 60mg 400mg Tablet exporter from India
- Hepcinat Plus Tablet supplier from Nagpur India
- Hepcinat Plus Daclatasvir Sofosbuvir exporter
- Daclatasvir 60mg Sofosbuvir 400mg supplier India
- Hepatitis C medicine exporter from India
- Hepatitis C antiviral tablets supplier
- Hepcinat Plus wholesale supplier India
- Hepcinat Plus pharmaceutical exporter Nagpur
- Hepcinat Plus tablets for international supply
- Daclatasvir Sofosbuvir tablets exporter India
- Hepatitis C medicines exporter to USA
- Hepatitis C medicine supplier to UK
- Hepcinat Plus supplier Australia
- Hepcinat Plus supplier Singapore
- Hepcinat Plus supplier Canada
- Hepcinat Plus supplier South Korea
- Hepcinat Plus supplier UAE
- Indian pharmaceutical exporter for Hepatitis C medicines
- DAA Hepatitis C medicine supplier India
- Chronic Hepatitis C treatment medicine supplier
- Sofosbuvir Daclatasvir pharmaceutical supplier
- Hepcinat Plus tablets international pharmaceutical supplier
- Hepcinat Plus medicine exporter from Nagpur
- Trusted Indian medicine exporter for HCV medicines
- Pharmaceutical export company Nagpur India
- Phoenix Exim Hepatitis C medicine exporter
- Phoenix Exim Hepcinat Plus supplier
- Phoenix Exim pharmaceutical exporter India
- Hepatitis C antiviral medicine export supplier
- Daclatasvir Sofosbuvir wholesale pharmaceutical supplier
Keywords







